Literature DB >> 9362197

Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.

F Y Lee1, H C Lin, Y T Tsai, F Y Chang, R H Lu, M C Hou, C P Li, C J Chu, S S Wang, S D Lee.   

Abstract

OBJECTIVES: Nitric oxide has been proposed as being responsible for the hyperdynamic circulation observed in portal hypertensive states. Substance P, a neuropeptide partly cleared by liver, induces vasodilation through the activation of the endothelial nitric oxide pathway. This study investigated the plasma levels of substance P in cirrhotic patients and the relationship of these levels to systemic and portal hemodynamics.
METHODS: Sixty-four patients with cirrhosis and 53 healthy controls had blood samples taken for determining plasma values of substance P by ELISA. Systemic and portal hemodynamics were measured on the same day of blood sampling using a Swan-Ganz catheterization and thermodilution technique.
RESULTS: Plasma levels of substance P were higher in cirrhotic patients than in healthy controls (45.7 +/- 2.0 vs 32.9 +/- 1.0 pg/ml, p < 0.001) and directly correlated with Child-Pugh's score (r = 0.52, p < 0.0001). Compared with compensated cirrhotic patients, decompensated cirrhotic patients had higher plasma levels of substance P accompanied by a lower systemic vascular resistance and higher hepatic venous pressure gradient. There was no significant correlation between plasma levels of substance P and systemic vascular resistance and hepatic venous pressure gradient. In addition, no significant difference in plasma levels of substance P was observed between cirrhotic patients with and cirrhotic patients without a hepatic venous pressure gradient > 12 mm Hg or between patients with and patients without large esophageal varices.
CONCLUSIONS: Plasma levels of substance P are increased in patients with cirrhosis and may contribute to the pathogenesis and/or maintenance of hyperdynamic circulation in decompensated patients. The severity of cirrhosis is more important than portal hypertension and the severity of esophageal varices for the development of increased plasma substance P levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362197

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

1.  Knockout of the Tachykinin Receptor 1 in the Mdr2-/- (Abcb4-/-) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver Fibrosis.

Authors:  Ludovica Ceci; Heather Francis; Tianhao Zhou; Thao Giang; Zhihong Yang; Fanyin Meng; Nan Wu; Lindsey Kennedy; Konstantina Kyritsi; Vik Meadows; Chaodong Wu; Suthat Liangpunsakul; Antonio Franchitto; Amelia Sybenga; Burcin Ekser; Romina Mancinelli; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2020-07-23       Impact factor: 4.307

2.  Measurement of plasma-derived substance P: biological, methodological, and statistical considerations.

Authors:  Donald E Campbell; Nancy Raftery; Richard Tustin; Nancy B Tustin; Michelle L Desilvio; Avital Cnaan; Pyone Pyone Aye; Andrew A Lackner; Steven D Douglas
Journal:  Clin Vaccine Immunol       Date:  2006-09-13

3.  Hepatorenal syndrome.

Authors:  Charles K F Ng; Michael H M Chan; Morris H L Tai; Christopher W K Lam
Journal:  Clin Biochem Rev       Date:  2007-02

4.  Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation.

Authors:  C P Li; S J Hwang; F Y Lee; F Y Chang; H C Lin; R H Lu; C J Chu; S D Lee
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 5.  Autocrine regulation of biliary pathology by activated cholangiocytes.

Authors:  Kendal Jensen; Marco Marzioni; Kamruzzaman Munshi; Syeda Afroze; Gianfranco Alpini; Shannon Glaser
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-22       Impact factor: 4.052

6.  Knockout of the neurokinin-1 receptor reduces cholangiocyte proliferation in bile duct-ligated mice.

Authors:  Shannon Glaser; Eugenio Gaudio; Anastasia Renzi; Romina Mancinelli; Yoshiyuki Ueno; Julie Venter; Mellanie White; Shelley Kopriva; Valorie Chiasson; Sharon DeMorrow; Heather Francis; Fanyin Meng; Marco Marzioni; Antonio Franchitto; Domenico Alvaro; Scott Supowit; Donald J DiPette; Paolo Onori; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-05-19       Impact factor: 4.052

Review 7.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

Review 8.  New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma.

Authors:  Leonardo Lorente
Journal:  World J Gastroenterol       Date:  2018-10-07       Impact factor: 5.742

9.  Patients with high serum substance P levels previously to liver transplantation for hepatocellular carcinoma have higher risk of one-year liver transplantation mortality.

Authors:  Leonardo Lorente; Sergio T Rodriguez; Pablo Sanz; Antonia Pérez-Cejas; Javier Padilla; Dácil Díaz; Antonio González; María M Martín; Alejandro Jiménez; Purificación Cerro; Manuel A Barrera
Journal:  Oncotarget       Date:  2018-04-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.